$155,300
median · per year, annualized USD
$103,325
median · per year, annualized USD
AI Scientist/Senior, Clinical & Molecular Genomics Modeling, BRAID
Senior Statistical Geneticist
Clinical Geneticist
Senior Principal Scientist/Principal Scientist, Real-World Evidence & Disease Genomics
Computational Genomics Senior Research Scientist
Physician - Geneticist
Scientist 3, Single Cell & Functional Genomics
Immunology Senior Research Scientist - Single-Cell Genomics
Senior Scientist I, Cancer Genomics, Clinical Biomarker Development
Senior Scientist, Functional Genomics
Senior Specialist I, Postmarketing Patient Safety and Pharmacovigilance Operations
Senior Medical Officer-Infectious Diseases & Pharmacovigilance
Pharmacovigilance QA Auditor Specialist
Pharmacovigilance Specialist - US - Remote
Drug Safety Associate - Bilingual - French - 12-Month Contract
| Company | Median | Roles |
|---|---|---|
Vertex Pharmaceuticals
|
$155,300 | 3 |
Roche
|
$179,400 | 2 |
| SJ St. Jude Children's Research Hospital | $105,300 | 2 |
| TM Tufts Medicine | $212,562 | 1 |
BridgeBio Pharma
|
$207,500 | 1 |
Endeavor Health
|
$192,000 | 1 |
Sanofi
|
$181,500 | 1 |
Revolution Medicines
|
$167,500 | 1 |
| Company | Median | Roles |
|---|---|---|
Corcept Therapeutics
|
$140,850 | 1 |
| GU Guidehouse | $113,000 | 1 |
Johnson & Johnson
|
$103,325 | 1 |
| WC Worldwide Clinical Trials | $74,500 | 1 |
Cencora
|
$31,298 | 1 |
| Location | Median | Roles |
|---|---|---|
| San Francisco | $153,000 | 3 |
The median for Geneticist is $155,300 per year (typically $143,850–$186,750), versus $103,325 for Pharmacovigilance ($74,500–$113,000). That puts Geneticist about 50% ahead at the median.
Both figures are computed live from active listings on JobsRadar and normalized to annualized USD, so Geneticist and Pharmacovigilance are compared on equal terms regardless of the currency each role was originally posted in. Only roles that publish a salary range feed the medians; numbers refresh every few hours as new roles post and older ones close, so this comparison reflects the market right now rather than a fixed survey. Use it as a directional benchmark when weighing one path against the other.